SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-20-000026
Filing Date
2020-02-05
Accepted
2020-02-05 07:30:27
Documents
4
Period of Report
2020-02-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq1plansforphase2aml.htm 8-K 19235
2 EXHIBIT 99.1 exh991-pressreleaseplansfo.htm EX-99.1 15160
3 moleculin-logo_horiza20.jpg GRAPHIC 132868
4 moleculinlogoa29.jpg GRAPHIC 11658
  Complete submission text file 0001659617-20-000026.txt   224129
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 20576361
SIC: 2834 Pharmaceutical Preparations